I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 3 studies | 18% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 3 studies | 18% ± 3% |
Insufficient scRNA-seq data for expression of BCORL1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1396.51 | 1445 / 1445 | 100% | 14.04 | 183 / 183 |
| thymus | 100% | 1960.67 | 653 / 653 | 100% | 11.30 | 602 / 605 |
| ovary | 100% | 1721.29 | 180 / 180 | 99% | 13.19 | 427 / 430 |
| skin | 100% | 1161.93 | 1808 / 1809 | 99% | 12.22 | 467 / 472 |
| intestine | 100% | 1475.58 | 966 / 966 | 99% | 9.62 | 520 / 527 |
| breast | 100% | 1389.59 | 459 / 459 | 99% | 11.80 | 1103 / 1118 |
| prostate | 100% | 1493.97 | 245 / 245 | 99% | 8.16 | 495 / 502 |
| lung | 100% | 1364.80 | 577 / 578 | 99% | 10.57 | 1139 / 1155 |
| stomach | 100% | 995.11 | 359 / 359 | 98% | 11.10 | 281 / 286 |
| uterus | 100% | 2057.95 | 170 / 170 | 97% | 9.72 | 446 / 459 |
| pancreas | 99% | 608.04 | 324 / 328 | 98% | 8.90 | 175 / 178 |
| brain | 97% | 762.72 | 2572 / 2642 | 99% | 8.13 | 698 / 705 |
| kidney | 100% | 1101.97 | 89 / 89 | 96% | 8.57 | 868 / 901 |
| bladder | 100% | 1457.90 | 21 / 21 | 96% | 7.93 | 485 / 504 |
| adrenal gland | 100% | 1347.12 | 258 / 258 | 93% | 6.58 | 215 / 230 |
| liver | 90% | 420.20 | 204 / 226 | 81% | 5.47 | 329 / 406 |
| adipose | 100% | 1527.35 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1593.59 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1247.36 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.68 | 1 / 1 |
| heart | 99% | 799.01 | 855 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 9.08 | 79 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 6.92 | 44 / 45 |
| peripheral blood | 98% | 1064.02 | 908 / 929 | 0% | 0 | 0 / 0 |
| muscle | 93% | 511.79 | 749 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 90% | 5.52 | 26 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006325 | Biological process | chromatin organization |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005634 | Cellular component | nucleus |
| GO_0003714 | Molecular function | transcription corepressor activity |
| Gene name | BCORL1 |
| Protein name | BCORL1 protein BCL-6 corepressor-like protein 1 (BCoR-L1) (BCoR-like protein 1) BCL6 corepressor like 1 Alternative protein BCORL1 |
| Synonyms | |
| Description | FUNCTION: Transcriptional corepressor. May specifically inhibit gene expression when recruited to promoter regions by sequence-specific DNA-binding proteins such as BCL6. This repression may be mediated at least in part by histone deacetylase activities which can associate with this corepressor. . |
| Accessions | V9GYD4 ENST00000540052.6 [Q5H9F3-3] ENST00000607874.1 ENST00000218147.11 [Q5H9F3-1] A0A087X1F0 ENST00000441294.1 H7C4B2 L8EB38 ENST00000488135.6 Q5H9F3 Q86YA6 |
